Prostate biopsy not always needed when PSA elevated
Researchers now say that not all men with elevated PSA (prostate specific antigen) levels need prostate biopsy to test for prostate cancer. A naturally occurring hormone can also raise PSA levels, and the test may not always mean prostate biopsy should be performed.
The findings come from researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison, led by Gary G. Schwartz, Ph.D., M.P.H. The PSA test is widely used to detect prostate cancer in men, but Schwartz says the test detects more than just cancer.
"PSA picks up any prostate activity, not just cancer. Inflammation and other factors can elevate PSA levels. If the levels are elevated, the man is usually sent for a biopsy. The problem is that, as men age, they often develop microscopic cancers in the prostate that are clinically insignificant. If it weren't for the biopsy, these clinically insignificant cancers, which would never develop into fatal prostate cancer, would never be seen.”
Elevated PSA levels can lead to unnecessary prostate biopsy. The researchers found that parathyroid hormone, a regulator of calcium in the body, can also lead to higher PSA levels in men who are healthy. In turn, prostate biopsy might lead to overtreatment of prostate cancer. The side effects for men can include impotence and urinary incontinence.
For the study, researchers examined 1,273 men who participated in the National Health and Nutrition Examination Survey 2005-2006. None of the men had prostate cancer, inflammation, or had a recent prostate biopsy.